Cardiovascular
DEVMET
| As per ESC 2024 | GDMT endorses beta blockers as the choice of therapy for an additional 19 Indicators |
|---|---|
| As per AHA 2023 | Beta blockers like Metoprolol improve BP and HR in CAD patients |
| As per ISH 2024 | Long term use of Beta blocker in Pre and Post MI in patients with CCD and reduced LVEF |
- Reduces sudden cardiac death by 38% (RRR)
- 63.1% Clinicians refers Metoprolol in young Hyp





